Bristol Myers (BMY) EVP Cristian Massacesi Exercises RSUs

What Happened Cristian Massacesi, EVP, Chief Medical Officer and Head of Development at Bristol Myers Squibb (BMY), had 51,172 restricted stock units convert into common shares on Aug 1, 2026. Of those shares, 26,175 were withheld to satisfy tax withholding obligations at $65.31 per share, a withholding value of $1,709,489. After withholding, 24,997 shares were issued to him net. This was a routine vesting/tax-withholding event rather than an open-market sale or purchase.

Key Details

• Transaction date: 2026-08-01; Filing date: 2026-08-04 (no late filing flag indicated).
• Conversion/Exercise: 51,172 RSUs converted to 51,172 shares (transaction code M).
• Tax withholding: 26,175 shares withheld and disposed to cover taxes at $65.31/share, total $1,709,489 (transaction code F).
• Net shares retained by insider: 24,997 (51,172 converted − 26,175 withheld).
• Shares owned after transaction: Not specified in the filing.
• Relevant footnotes: RSUs vest in four equal annual installments (F1); withheld shares were used to pay taxes upon vesting (F2); each RSU converts 1:1 into one share upon vesting (F3).

Context This was a vesting and tax-withholding event for restricted stock units (RSUs). The withholding of shares to satisfy tax obligations is routine and should not be read as a market sale of shares; it represents part of the compensation tax settlement rather than a directional insider trade. Transaction codes: M = exercise/conversion of derivative (RSU conversion), F = shares withheld for taxes.